Pain and neuropathy in cancer survivors: Surgery, radiation, and chemotherapy can cause pain; research could improve its detection and treatment

Cancer Nursing

Volumn 29, Issue 2 SUPPL., 2006, Pages 39-47

  Polomano, Rosemary C ^a   Farrar, John T ^b  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF NURSING   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; ANTICONVULSIVE AGENT; ANTIDIARRHEAL AGENT; BUPIVACAINE; CAPSAICIN; CARBOPLATIN; CISPLATIN; CYTARABINE; DEXTROMETHORPHAN; FLUOROURACIL; GLUTAMINE; GLUTATHIONE; METHOTREXATE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NERVE GROWTH FACTOR; OPIATE; OXALIPLATIN; PACLITAXEL; STEROID; SUCRALFATE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; VINBLASTINE; VINBLASTINE SULFATE; VINCRISTINE; VINCRISTINE SULFATE; ANTINEOPLASTIC AGENT;

BLADDER DYSFUNCTION; BRACHIAL PLEXUS NEUROPATHY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; CONSTIPATION; DIARRHEA; DRUG EFFICACY; DYSESTHESIA; ENDOMETRIUM CARCINOMA; FIBROSIS; HEAD AND NECK CANCER; HODGKIN DISEASE; HUMAN; LOW BACK PAIN; MASTECTOMY; MOTOR DYSFUNCTION; NEUROPATHIC PAIN; ORTHOSTATIC HYPOTENSION; PAINFUL DEFECATION; PARALYTIC ILEUS; PARESTHESIA; PERIPHERAL NEUROPATHY; PHANTOM PAIN; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROCTITIS; PROSTATE CARCINOMA; REVIEW; SENSORIMOTOR NEUROPATHY; SPINAL CORD DISEASE; THORACOTOMY; UTERINE CERVIX CARCINOMA; AMPUTATION; CHRONIC DISEASE; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HEALTH SERVICE; HEALTH SURVEY; INCIDENCE; METHODOLOGY; MONONEUROPATHY; NEOPLASM; NURSE ATTITUDE; NURSING ASSESSMENT; ONCOLOGY NURSING; ORGANIZATION AND MANAGEMENT; PAIN; POLYNEUROPATHY; PREVALENCE; RADIOTHERAPY; STATISTICS; SURVIVOR; UNITED STATES;

AMPUTATION; ANTINEOPLASTIC AGENTS; CHRONIC DISEASE; EVIDENCE-BASED MEDICINE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INCIDENCE; MASTECTOMY; MONONEUROPATHIES; NEOPLASMS; NURSE'S ROLE; NURSING ASSESSMENT; ONCOLOGIC NURSING; PAIN; POLYNEUROPATHIES; POPULATION SURVEILLANCE; PREVALENCE; QUALITY OF HEALTH CARE; RADIOTHERAPY; RESEARCH DESIGN; SURVIVORS; THORACOTOMY; UNITED STATES;

EID: 33746021112     PISSN: 0162220X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002820-200603002-00015     Document Type: Review

References (60)

1. Merskey H, Bogduk N, editors. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. 2nd ed. Seattle, WA: IASP Press; 1994.
2. Chua KS, et al. Pain and loss of function in head and neck cancer survivors. J Pain Symptom Manage 1999;18(3):193-202.
3. Marchettini P, et al. Iatrogenic painful neuropathic complications of surgery in cancer. Acta Anaesthesiol Scand 2001;45(9):1090-4.
4. Karmakar MK, Ho AM. Postthoracotomy pain syndrome. Thorac Surg Clin 2004;14(3):345-52.
5. Macdonald L, et al. Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br J Cancer 2005;92(2):225-30.
6. Polomano RC, Bennett GJ. Chemotherapy-evoked painful peripheral neuropathy. Pain Med 2001;2(1):8-14.
7. Visovsky C. Chemotherapy-induced peripheral neuropathy. Cancer Invest 2003;21(3):439-51.
8. Azinovic I, et al. Long-term normal tissue effects of intraoperative electron radiation therapy (IOERT): late sequelae, tumor recurrence, and second malignancies. Int J Radiat Oncol Biol Phys 2001;49(2):597-604.
9. Lyne ME, et al. Pain management issues for cancer survivors. Cancer Pract 2002;10 Suppl 1:S27-32.
10. Portenoy RK, Conn M. Cancer pain syndromes. In: Bruera E, Portenoy RK, editors. Cancer pain: assessment and management. New York: Cambridge University Press; 2003. p. 89-110.
11. van Wilgen CP, et al. Morbidity of the neck after head and neck cancer therapy. Head Neck 2004;26(9):785-91.
12. Ververs JM, et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 2001;37(8):991-9.
13. Stevens PE, et al. Prevalence, characteristics, and impact of postmastectomy pain syndrome: an investigation of women's experiences. Pain 1995;61(1):61-8.
14. Bosompra K, et al. Swelling, numbness, pain, and their relationship to arm function among breast cancer survivors: a disablement process model perspective. Breast J 2002;8(6):338-48.
15. Carpenter JS, et al. Risk factors for pain after mastectomy/lumpectomy. Cancer Pract 1999;7(2):66-70.
16. Eversley R, et al. Post-treatment symptoms among ethnic minority breast cancer survivors. Oncol Nurs Forum 2005;32(2):250-6.
17. Hautkappe M, et al. Review of the effectiveness of capsaicin for painful cutaneous disorders and neural dysfunction. Clin J Pain 1998;14(2):97-106.
18. Reuben SS, et al. Evaluation of efficacy of the perioperative administration of venlafaxine XR in the prevention of postmastectomy pain syndrome. J Pain Symptom Manage 2004;27(2):133-9.
19. Perttunen K, et al. Chronic pain after thoracic surgery: a follow-up study. Acta Anaesthesiol Scand 1999;43(5):563-7.
20. Dajczman E, et al. Long-term postthoracotomy pain. Chest 1991;99(2):270-4.
21. Erdek MA, Staats PS. Chronic pain and thoracic surgery. Thorac Surg Clin 2005;15(1):123-30.
22. Gotoda Y, et al. The morbidity, time course and predictive factors for persistent post-thoracotomy pain. Eur J Pain 2001;5(1):89-96.
23. Senturk M, et al. The effects of three different analgesia techniques on long-term postthoracotomy pain. Anesth Analg 2002;94(1):11-5.
24. Pourel N, et al. Quality of life in long-term survivors of oropharynx carcinoma. Int J Radiat Oncol Biol Phys 2002;54(3):742-51.
25. Melzack R. Phantom limb pain: implications for treatment of pathologic pain. Anesthesiology 1971;35(4):409-19.
26. Jensen TS, et al. Immediate and long-term phantom limb pain in amputees: incidence, clinical characteristics and relationship to pre-amputation limb pain. Pain 1985;21(3):267-78.
27. Ben Abraham R, et al. Dextromethorphan for phantom pain attenuation in cancer amputees: a double-blind crossover trial involving three patients. Clin J Pain 2002;18(5):282-5.
28. Ben Abraham R, et al. Dextromethorphan mitigates phantom pain in cancer amputees. Ann Surg Oncol 2003;10(3):268-74.
29. Bucci MK, et al. Advances in radiation therapy: conventional to 3D, to IMRT, to 4D, and beyond. CA Cancer J Clin 2005;55(2):117-34.
30. Gordils-Perez J, et al. Advances in radiation treatment of patients with breast cancer. Clin J Oncol Nurs 2003;7(6):629-36.
31. Johansson S, et al. Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiat Oncol Biol Phys 2000;48(3):745-50.
32. McFarlane VJ, et al. Cervical neuropathy following mantle radiotherapy. Clin Oncol (R Coll Radiol) 2002;14(6):468-71.
33. Bye A, et al. Health-related quality of life and occurrence of intestinal side effects after pelvic radiotherapy - evaluation of long-term effects of diagnosis and treatment. Acta Oncol 2000;39(2):173-80.
34. Ajlouni M. Radiation-induced proctitis. Curr Treat Options Gastroenterol 1999;2(1):20-6.
35. Colwell JC, Goldberg M. A review of radiation proctitis in the treatment of prostate cancer. J Wound Ostomy Continence Nurs 2000;27(3):179-87.
36. Aley KO, et al. Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans. Neuroscience 1996;73(1):259-65.
37. Boyle FM, et al. Amelioration of experimental cisplatin and paclitaxel neuropathy with glutamate. J Neurooncol 1999;41(2):107-16.
38. Polomano RC, et al. A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain 2001;94(3):293-304.
39. Dropcho EJ. Neurotoxicity of cancer chemotherapy. Semin Neurol 2004;24(4):419-26.
40. Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol 2002;249(1):9-17.
41. LoMonaco M, et al. Cisplatin neuropathy: clinical course and neurophysiological findings. J Neurol 1992;239(4):199-204.
42. Verstappen CC, et al. Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs 2003;63(15):1549-63.
43. Strumberg D, et al. Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer. Ann Oncol 2002;13(2):229-36.
44. Fossa SD. Long-term sequelae after cancer therapy - survivorship after treatment for testicular cancer. Acta Oncol 2004;43(2):134-41.
45. Rock E, DeMichele A. Nutritional approaches to late toxicities of adjuvant chemotherapy in breast cancer survivors. J Nutr 2003;133(11 Suppl 1):3785S-93S.
46. Armstrong T, et al. Chemotherapy-induced peripheral neuropathy. Oncol Nurs Forum 2005;32(2):305-11.
47. Cavaletti G, Zanna C. Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity. Eur J Cancer 2002;38(14):1832-7.
48. Savarese DM, et al. Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat Rev 2003;29(6):501-13.
49. Argyriou AA, et al. Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial. Neurology 2005;64(1):26-31.
50. Cata JP, et al. Spinal cord stimulation relieves chemotherapyinduced pain: a clinical case report. J Pain Symptom Manage 2004;27(1):72-8.
51. Rauch P, et al. Quality of life among disease-free survivors of rectal cancer. J Clin Oncol 2004;22(2):354-60.
52. Panchal SJ, et al. Adult cancer pain. Jenkintown, PA: National Comprehensive Cancer Network; 2005. (Clinical practice guidelines in oncology, v.2.2005). http://www.nccn.org/professionals/physician_gls/PDF/pain.pdf.
53. Carr DB, et al. Evidence report on the treatment of pain in cancer patients. J Natl Cancer Inst Monogr 2004(32):23-31.
54. Dworkin RH, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003;60(11):1524-34.
55. Gordon DB, Love G. Pharmacologic management of neuropathic pain. Pain Manag Nurs 2004;5(4 Suppl 1):19-33.
56. Stacey BR. Management of peripheral neuropathic pain. Am J Phys Med Rehabil 2005;84(3 Suppl):S4-16.
57. Arnstein P. Chronic neuropathic pain: issues in patient education. Pain Manag Nurs 2004;5(4 Suppl 1):34-41.
58. Tesauro GM, et al. Survivorship resources for post-treatment cancer survivors. Cancer Pract 2002;10(6):277-83.
59. Almadrones L, et al. Psychometric evaluation of two scales assessing functional status and peripheral neuropathy associated with chemotherapy for ovarian cancer: a gynecologic oncology group study. Oncol Nurs Forum 2004;31(3):615-23.
60. Visovsky C, Daly BJ. Clinical evaluation and patterns of chemotherapy-induced peripheral neuropathy. J Am Acad Nurse Pract 2004;16(8):353-9.